Phase 3 Dengue Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)
Dengue Fever
Takeda800 enrolled7 locationsNCT06579755
Recruiting
Phase 3
Butantan-DV Vaccine in Elderly Populations (DEN-04-IB)
Dengue
Butantan Institute997 enrolled5 locationsNCT06891950
Recruiting
Phase 3
A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers
Dengue Fever
Takeda212 enrolled4 locationsNCT06665035
Recruiting
Phase 2Phase 3
Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients
DengueMontelukastTransaminases
Phramongkutklao College of Medicine and Hospital82 enrolled1 locationNCT06747130